Medical dictionary
Medical terminology normalized via MeSH, ICD-11, SNOMED CT.
62,341 terms indexed
structure in first source
a histamine H3 receptor antagonist; structure in first source
from Streptomyces sp.; structure in first source
structure in first source
an NSAID; structure in first source
from the fibrous roots of Liriope spicata var. prolifera; structure in first source
from the fibrous roots of Liriope spicata var. prolifera; structure in first source
structure in first source
from the stem barks of Stereospermum acuminatissimum; structure in first source
from Cinnamomum philippinense; structure in first source
structure in first source
an antiviral agent; structure in first source
PET imaging agent for the Imidazoline2 binding site; structure in first source
structure in first source
- C5868352-(4-((2-(2-ethoxyphenoxy)ethyl)amino)butyl)tetrahydro-1H-pyrrolo(1,2-c)imidazole-1,3(2H)-dioneMeSH
structure in first source
structure in first source
structure in first source
- C5830852-(4-((3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl)methyl))-1-piperazinyl-N-(4-methylphenyl)acetamideMeSH
structure in first source
structure in first source
structure in first source
a glucocorticoid receptor modulator; structure in first source
structure in first source
has antineoplastic activity
- C5706632-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazol-3yl)vinyl)-1H-pyrazol-1-yl)ethanolMeSH
structure in first source
an mGlu5 positive modulator; structure in first source
a PORCN acyltransferase inhibitor; structure in first source
a prostaglandin-E synthase inhibitor; structure in first source
inhibits protein kinase C theta; structure in first source
disrupts interactions between glucokinase and glucokinase regulatory protein
attenuates proinflammatory cytokine production
an NSAID; structure in first source
structure in first source
a dye; structure in first source
a microtubule inhibitor with antineoplastic activity; structure in first source
has antineoplastic activity; structure in first source
structure in first source
an NMDA receptor ligand; structure in first source
- C5874982-(4-bromo-3-methylphenyl)-5-thioxo-5,6-dihydro-(1,2,4)triazolo(1,5-a)(1,3,5)triazin-7(4H)-oneMeSH
structure in first source
has both antioxidant and antidyslipidemic activities; structure in first source
structure in first source
antineoplastic; structure in first source
structure in first source
structure in first source
structure in first source
structure in first source
inhibits phytoene-desaturase; structure in first source
structure in first source